Cargando…

Effect of acute iron infusion on insulin secretion: A randomized, double-blind, placebo-controlled trial

BACKGROUND: Chronic exposure to high iron levels increases diabetes risk partly by inducing oxidative stress, but the consequences of acute iron administration on beta cells are unknown. We tested whether the acute administration of iron for the correction of iron deficiency influenced insulin secre...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaccard, Evrim, Seyssel, Kévin, Gouveia, Alexandre, Vergely, Catherine, Baratali, Laila, Gubelmann, Cédric, Froissart, Marc, Favrat, Bernard, Marques-Vidal, Pedro, Tappy, Luc, Waeber, Gérard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092517/
https://www.ncbi.nlm.nih.gov/pubmed/35706490
http://dx.doi.org/10.1016/j.eclinm.2022.101434
_version_ 1784705156901765120
author Jaccard, Evrim
Seyssel, Kévin
Gouveia, Alexandre
Vergely, Catherine
Baratali, Laila
Gubelmann, Cédric
Froissart, Marc
Favrat, Bernard
Marques-Vidal, Pedro
Tappy, Luc
Waeber, Gérard
author_facet Jaccard, Evrim
Seyssel, Kévin
Gouveia, Alexandre
Vergely, Catherine
Baratali, Laila
Gubelmann, Cédric
Froissart, Marc
Favrat, Bernard
Marques-Vidal, Pedro
Tappy, Luc
Waeber, Gérard
author_sort Jaccard, Evrim
collection PubMed
description BACKGROUND: Chronic exposure to high iron levels increases diabetes risk partly by inducing oxidative stress, but the consequences of acute iron administration on beta cells are unknown. We tested whether the acute administration of iron for the correction of iron deficiency influenced insulin secretion and the production of reactive oxygen species. METHODS: Single-center, double-blinded, randomized controlled trial conducted between June 2017 and March 2020. 32 women aged 18 to 47 years, displaying symptomatic iron deficiency without anaemia, were recruited from a community setting and randomly allocated (1:1) to a single infusion of 1000 mg intravenous ferric carboxymaltose (iron) or saline (placebo). The primary outcome was the between group mean difference from baseline to day 28 in first and second phase insulin secretion, assessed by a two-step hyperglycaemic clamp. All analyses were performed by intention to treat. This trial was registered in ClinicalTrials.gov NCT03191201. FINDINGS: Iron infusion did not affect first and second phase insulin release. For first phase, the between group mean difference from baseline to day 28 was 0 μU × 10 min/mL [95% CI, -22 to 22, P = 0.99]. For second phase, it was -5 μUx10min/mL [95% CI, -161 to 151; P = 0.95] at the first plateau of the clamp and -249 μUx10min/mL [95% CI, -635 to 137; P = 0.20] at the second plateau. Iron infusion increased serum ascorbyl/ascorbate ratio, a marker of plasma oxidative stress, at day 14, with restoration of normal ratio at day 28 relative to placebo. Finally, high-sensitive C-reactive protein levels remained similar among groups. INTERPRETATION: In iron deficient women without anaemia, intravenous administration of 1000 mg of iron in a single sitting did not impair glucose-induced insulin secretion despite a transient increase in the levels of circulating reactive oxygen species. FUNDING: The Swiss National Science Foundation, University of Lausanne and Leenaards, Raymond-Berger and Placide Nicod Foundations.
format Online
Article
Text
id pubmed-9092517
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90925172022-06-14 Effect of acute iron infusion on insulin secretion: A randomized, double-blind, placebo-controlled trial Jaccard, Evrim Seyssel, Kévin Gouveia, Alexandre Vergely, Catherine Baratali, Laila Gubelmann, Cédric Froissart, Marc Favrat, Bernard Marques-Vidal, Pedro Tappy, Luc Waeber, Gérard eClinicalMedicine Articles BACKGROUND: Chronic exposure to high iron levels increases diabetes risk partly by inducing oxidative stress, but the consequences of acute iron administration on beta cells are unknown. We tested whether the acute administration of iron for the correction of iron deficiency influenced insulin secretion and the production of reactive oxygen species. METHODS: Single-center, double-blinded, randomized controlled trial conducted between June 2017 and March 2020. 32 women aged 18 to 47 years, displaying symptomatic iron deficiency without anaemia, were recruited from a community setting and randomly allocated (1:1) to a single infusion of 1000 mg intravenous ferric carboxymaltose (iron) or saline (placebo). The primary outcome was the between group mean difference from baseline to day 28 in first and second phase insulin secretion, assessed by a two-step hyperglycaemic clamp. All analyses were performed by intention to treat. This trial was registered in ClinicalTrials.gov NCT03191201. FINDINGS: Iron infusion did not affect first and second phase insulin release. For first phase, the between group mean difference from baseline to day 28 was 0 μU × 10 min/mL [95% CI, -22 to 22, P = 0.99]. For second phase, it was -5 μUx10min/mL [95% CI, -161 to 151; P = 0.95] at the first plateau of the clamp and -249 μUx10min/mL [95% CI, -635 to 137; P = 0.20] at the second plateau. Iron infusion increased serum ascorbyl/ascorbate ratio, a marker of plasma oxidative stress, at day 14, with restoration of normal ratio at day 28 relative to placebo. Finally, high-sensitive C-reactive protein levels remained similar among groups. INTERPRETATION: In iron deficient women without anaemia, intravenous administration of 1000 mg of iron in a single sitting did not impair glucose-induced insulin secretion despite a transient increase in the levels of circulating reactive oxygen species. FUNDING: The Swiss National Science Foundation, University of Lausanne and Leenaards, Raymond-Berger and Placide Nicod Foundations. Elsevier 2022-05-06 /pmc/articles/PMC9092517/ /pubmed/35706490 http://dx.doi.org/10.1016/j.eclinm.2022.101434 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Articles
Jaccard, Evrim
Seyssel, Kévin
Gouveia, Alexandre
Vergely, Catherine
Baratali, Laila
Gubelmann, Cédric
Froissart, Marc
Favrat, Bernard
Marques-Vidal, Pedro
Tappy, Luc
Waeber, Gérard
Effect of acute iron infusion on insulin secretion: A randomized, double-blind, placebo-controlled trial
title Effect of acute iron infusion on insulin secretion: A randomized, double-blind, placebo-controlled trial
title_full Effect of acute iron infusion on insulin secretion: A randomized, double-blind, placebo-controlled trial
title_fullStr Effect of acute iron infusion on insulin secretion: A randomized, double-blind, placebo-controlled trial
title_full_unstemmed Effect of acute iron infusion on insulin secretion: A randomized, double-blind, placebo-controlled trial
title_short Effect of acute iron infusion on insulin secretion: A randomized, double-blind, placebo-controlled trial
title_sort effect of acute iron infusion on insulin secretion: a randomized, double-blind, placebo-controlled trial
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092517/
https://www.ncbi.nlm.nih.gov/pubmed/35706490
http://dx.doi.org/10.1016/j.eclinm.2022.101434
work_keys_str_mv AT jaccardevrim effectofacuteironinfusiononinsulinsecretionarandomizeddoubleblindplacebocontrolledtrial
AT seysselkevin effectofacuteironinfusiononinsulinsecretionarandomizeddoubleblindplacebocontrolledtrial
AT gouveiaalexandre effectofacuteironinfusiononinsulinsecretionarandomizeddoubleblindplacebocontrolledtrial
AT vergelycatherine effectofacuteironinfusiononinsulinsecretionarandomizeddoubleblindplacebocontrolledtrial
AT baratalilaila effectofacuteironinfusiononinsulinsecretionarandomizeddoubleblindplacebocontrolledtrial
AT gubelmanncedric effectofacuteironinfusiononinsulinsecretionarandomizeddoubleblindplacebocontrolledtrial
AT froissartmarc effectofacuteironinfusiononinsulinsecretionarandomizeddoubleblindplacebocontrolledtrial
AT favratbernard effectofacuteironinfusiononinsulinsecretionarandomizeddoubleblindplacebocontrolledtrial
AT marquesvidalpedro effectofacuteironinfusiononinsulinsecretionarandomizeddoubleblindplacebocontrolledtrial
AT tappyluc effectofacuteironinfusiononinsulinsecretionarandomizeddoubleblindplacebocontrolledtrial
AT waebergerard effectofacuteironinfusiononinsulinsecretionarandomizeddoubleblindplacebocontrolledtrial